Canaccord Raises Regeneron Price Target to $922 From $875
Canaccord Genuity maintained its Buy rating on Regeneron, according to the supplied ratings-action report.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Canaccord Genuity maintained its Buy rating on Regeneron, according to the supplied ratings-action report.